Flores R, Papenfuss M, Klimecki WT, Giuliano AR: Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer. 2006, 118: 1187-1193. 10.1002/ijc.21477.
Article
CAS
PubMed
Google Scholar
Tsai HT, Wu CH, Lai HL, Li RN, Tung YC, Chuang HY, Wu TN, Lin LJ, Ho CK, Liu HW, Wu MT: Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2544-2549. 10.1158/1055-9965.EPI-05-0240.
Article
CAS
PubMed
Google Scholar
Schlecht NF, Trevisan A, Duarte-Franco E, Rohan T, Ferenczy A, Villa LL, Franco EL: Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer. 2003, 103: 519-524. 10.1002/ijc.10846.
Article
CAS
PubMed
Google Scholar
Ylitalo N, Sorensen P, Josefsson AM, Magnusson PKE, Anderson PK, Ponten J, Adami HO, Gyllensten UB, Melbye M: Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet. 2000, 355: 2194-2198. 10.1016/S0140-6736(00)02402-8.
Article
CAS
PubMed
Google Scholar
Van Duin M, Snijders PJE, Schrijnemakers HFJ, Voorhorst FJ, Rozendaal L, Nobbenhuis MAE, van den Brule AJC, Verheijen RHM, Helmerhorst TJ, Meijer CJLM: Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer. 2002, 98: 590-595. 10.1002/ijc.10232.
Article
CAS
PubMed
Google Scholar
Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD: High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer. 2007, 121: 2787-2793. 10.1002/ijc.23012.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, PalanP BasuJ, Tachezy R, Lewis R, Romney S: Persistant genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995, 87: 1365-1371. 10.1093/jnci/87.18.1365.
Article
CAS
PubMed
Google Scholar
Dalstein V, Riethmuller D, Pretet JL, Le Bail C, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C: Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003, 106: 396-403. 10.1002/ijc.11222.
Article
CAS
PubMed
Google Scholar
Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. New Engl J Med. 1998, 338: 423-428. 10.1056/NEJM199802123380703.
Article
CAS
PubMed
Google Scholar
Fontaine J, Hankins C, Money D, Rachlis A, Pourreaux K, Ferenczy A, Coutlee F: Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV. J Clin Virol. 2008, 43: 307-312. 10.1016/j.jcv.2008.07.013.
Article
CAS
PubMed
Google Scholar
Kulmala SM, Shabalova IP, Petrovitchev N, Syrjanen KJ, Gyllensten UB, Johansson BC, Syrjanen SM: Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study. Cancer Epidemiol Biomarkers Prev. 2007, 16: 17-22. 10.1158/1055-9965.EPI-06-0649.
Article
CAS
PubMed
Google Scholar
Trottier H, Mahmud S, Prado J, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL: Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis. 2008, 197: 1436-1447. 10.1086/587698.
Article
PubMed
Google Scholar
Cuzick J: Viral load as surrogate for persistence in cervical human papillomavirus infection. Development in Cervical Cancer Screening and prevention. Edited by: Franco EL, Monsonego J. 1997, Blackwell, Oxford, 372-378.
Google Scholar
Doorbar J: Papillomavirus life cycle organization and biomarker selection. Dis Markers. 2007, 23: 297-313.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kulmala SMA, Syrjanen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi PT, Syrjanen KJ, Johansson BC: Early integration of high copy HPV-16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol. 2007, 59: 513-517. 10.1136/jcp.2004.024570.
Article
Google Scholar
Peitsaro P, Johansson B, Syrjanen S: Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol. 2002, 40: 886-891. 10.1128/JCM.40.3.886-891.2002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thiery F: Transcription regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology. 2009, 384: 375-379. 10.1016/j.virol.2008.11.014.
Article
Google Scholar
Fontaine J, Hankins C, Mayrand MH, Lefevre J, Money D, Gagnon S, Rachlis A, Pourreaux K, Ferenczy A, Coutlee F: High levels of episomal and integrated HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS. 2005, 19: 785-794. 10.1097/01.aids.0000168972.65304.6b.
Article
PubMed
Google Scholar
Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK: Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infections in cervical neoplasia. J Infect Dis. 2006, 194: 1706-1712. 10.1086/509622.
Article
CAS
PubMed
Google Scholar
Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, Birembaut P, Clavel C: HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer. 2007, 121: 2198-2204. 10.1002/ijc.22959.
Article
CAS
PubMed
Google Scholar
Matovina M, Sabol I, Grubisic G, Gasperov NM, Grce M: Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol. 2009, 113: 120-127. 10.1016/j.ygyno.2008.12.004.
Article
CAS
PubMed
Google Scholar
Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Coutlée F, Franco EL: The natural history of type-specific HPV infections in female university students. Cancer. Epidemiol Biom Prev. 2003, 12: 485-490.
Google Scholar
Richardson H, Abrahamowicz M, Tellier PP, Kelsall G, du-Berger R, Ferenczy A, Coutlee F, Franco EL: Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1149-1156. 10.1158/1055-9965.EPI-04-0230.
Article
PubMed
Google Scholar
Lefevre J, Hankins C, Pourreaux K: The Canadian Women's HIV study Group, and F. Coutlée. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J Med Virol. 2004, 72: 132-137. 10.1002/jmv.10539.
Article
CAS
PubMed
Google Scholar
Lefevre J, Hankins C, Pourreaux K, Voyer H: The Canadian Women's HIV study Group, and F. Coutlée. Real -time PCR assays using internal Controls for quantitation of HPV-16 and b-globin DNA in cervicovaginal lavages. J Virol Methods. 2003, 144: 135-144. 10.1016/j.jviromet.2003.09.003.
Article
Google Scholar
Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV: Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J. Virol Methods. 2003, 112: 23-33. 10.1016/S0166-0934(03)00186-1.
Article
CAS
Google Scholar
Weissenborn SJ, Funke AM, Hellmich M, Mallmann P, Fuschs PG, Pfister HG, Wieland : Oncogenic Human papillomavirus DNA loads in human immunodeficiency virus-positive women with High-grade cervical lesions are strongly elevated. J Clin Microbiol. 2003, 41: 2763-2767. 10.1128/JCM.41.6.2763-2767.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Azizi N, Brazete J, Hankins C, Money J, Fontaine A, Koushik A, Rachlis K, Pourreaux A, Franco Ferenczy E, Coutlee F: Influence of HPV-16 E2 polymorphism on quantitation of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. J Gen Virol. 2008, 89: 1716-1728. 10.1099/vir.0.83579-0.
Article
CAS
PubMed
Google Scholar
Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferenczy A, Matlashewski , Roger M, Franco EL, Coutlée F: Viral load of episomal and integrated forms of Human papillomavirus type 33 in High-grade squamous intraepithelial lesions of the uterine cervix. Int J Cancer. 2007, 121: 2674-2681. 10.1002/ijc.23006.
Article
CAS
PubMed
Google Scholar
Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, Smith DI: Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 2000, 60: 5916-5921.
CAS
PubMed
Google Scholar
Cox DR: Regression Models and Life Tables. Journal of the Royal Statistical Society. 1972, 34: 187-220. Series B
Google Scholar
Liang KY, Zeger SL: Generalized linear model in longitudinal data analysis. Biometrika. 1986, 73: 13-22. 10.1093/biomet/73.1.13.
Article
Google Scholar
Hardin JW, Hilbe JM: Generalized estimating equations. 2003, New York. Chapman and Hall/CRC
Google Scholar
Ruutu MP, Kulmala SM, Peitsaro P, Syrjanen SM: The performance of the HPV16 real-time PCR integration assay. Clin Biochem. 2008, 41: 423-428. 10.1016/j.clinbiochem.2007.12.014.
Article
CAS
PubMed
Google Scholar
Snijders PJF, Hogewoning CJ, Hesselink HT, Berkhof J, Voohorst FJ, Bleeker MC, Meijer CJLM: Determination of viral load thresholds in cervical scrapes to rule out CIN3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int J Cancer. 2006, 119: 1102-1107. 10.1002/ijc.21956.
Article
CAS
PubMed
Google Scholar
Coutlee F, Mayrand MH, Roger M, Franco EL: Detection and typing of human papillomavirus nucleic acids in biological fluids. Public Health Genomics. 2009, 12: 308-318. 10.1159/000214921.
Article
PubMed
Google Scholar
Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, Van Assche FA: Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest. 1995, 39: 34-38. 10.1159/000292372.
Article
CAS
PubMed
Google Scholar
Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MS, Abrahamsen M, Inserra P: Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control. 2002, 13: 839-846. 10.1023/A:1020668232219.
Article
PubMed
Google Scholar
Burchell AN, Tellier PP, Hanley J, Coutlee F, Franco EL: HPV infection in young adult couples in new sexual relationships: the importance of partner's HPV status. Sex Transm Dis. 2010, 37 (1): 34-40. 10.1097/OLQ.0b013e3181b35693.
Article
PubMed
Google Scholar
Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Snijders PJ, Starink TM, Berkhof J, Meijer CJ: Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer. 2003, 107: 804-810. 10.1002/ijc.11473.
Article
CAS
PubMed
Google Scholar
Wang SS, Hildesheim A: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr. 2003, 35-40.
Google Scholar
Lehoux M, D'Abramo CM, Archambault J: Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics. 2009, 12: 268-280. 10.1159/000214918.
Article
PubMed
PubMed Central
Google Scholar
Burk RD, Chen Z, Van Doorslaer K: Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics. 2009, 12: 281-290. 10.1159/000214919.
Article
PubMed
PubMed Central
Google Scholar
Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, Pannuti CS: Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gyn Oncol. 2004, 92: 225-231. 10.1016/j.ygyno.2003.10.004.
Article
Google Scholar
An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun M, Kim SH, Jeong JK: Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer. 2003, 97: 1672-1680. 10.1002/cncr.11235.
Article
PubMed
Google Scholar
Collins SI, Williams CC, Wen K, Young LS, Roberts S, Murray PG, Woodman CB: Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. Cancer Res. 2009, 69: 3828-3832. 10.1158/0008-5472.CAN-08-3099.
Article
CAS
PubMed
Google Scholar
Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM: Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol. 2006, 44: 1755-1762. 10.1128/JCM.44.5.1755-1762.2006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P: HPV testing in primary screening of older women. Br J Cancer. 1999, 81: 554-8. 10.1038/sj.bjc.6690730.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cuschieri KS, Cubie HA, Whitley MW, Gilkison G, Arends MJ, Graham C, McGoogan E: Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol. 2005, 58: 946-950. 10.1136/jcp.2004.022863.
Article
CAS
PubMed
PubMed Central
Google Scholar